Patent ID: 7605308

Claim:
An isolated nucleic acid comprising a nucleotide sequence selected from the group consisting of: a) a nucleotide sequence comprising at least 20 consecutive nucleotides of the complement of the nucleotide sequence of SEQ ID NO: 1; b) a nucleotide sequence comprising at least 30 consecutive nucleotides of the complement of the nucleotide sequence of SEQ ID NO: 1; c) a nucleotide sequence comprising at least 50 consecutive nucleotides of the complement of the nucleotide sequence of SEQ ID NO: 1; d) a nucleotide sequence comprising at least 75 consecutive nucleotides of the complement of the nucleotide sequence of SEQ ID NO: 1; e) a nucleotide sequence comprising at least 100 consecutive nucleotides of the complement of the nucleotide sequence of SEQ ID NO: 1; f) a nucleotide sequence comprising at least 125 consecutive nucleotides of the complement of the nucleotide sequence of SEQ ID NO: 1; g) a nucleotide sequence comprising at least 150 consecutive nucleotides of the complement of the nucleotide sequence of SEQ ID NO: 1; h) a nucleotide sequence comprising at least 200 consecutive nucleotides of the complement of the nucleotide sequence of SEQ ID NO: 1; and i) a nucleotide sequence having at least 95% identity with the nucleotide sequence of any of (a)-(h) above.